1-877-892-3553

C'ELLE : YOUR MONTHLY MIRACLE

Science Showcase

Clinical uses of adult stem cells
“Adult stem cells, in particular, bone marrow cells and cord cells, already have well established clinical histories, and cannot be patented. They have shown great promise and potential in treating a variety of diseases, including, more recently, brain and spinal cord repair in animal models. Adult stem cells can be harvested directly from the patients requiring transplant, and used without culture or after only brief periods of culture, thereby avoiding immune rejection and all other technical problems and risks arising from prolonged cell culture. Adult stem cells appear to have all the developmental potential of ES [embryonic stem] cells, even though the precise mechanisms are debated, without the risks of cancer. On account of the ease of harvesting, handling and use, and the lack of patents, costs are minimal, and hence the treatments developed are likely to be widely available to all. Finally, there is little or no moral objection to using them." (Quoted from www.i-sis.org.uk)  

The current clinical uses of adult stem cells include:

  • Adult stem cells from the brain and from bone marrow, as well as from umbilical cord blood, have all provided therapeutic benefit after stroke. These cells are capable of "homing in" on sites of neurological damage.
  • Adult stem cells are capable of regrowth and reconnection in the spinal cord after injury.
  • Liver and pancreatic adult stem cells can form insulin secreting islets, for the treatment of diabetes.
  • Stem cells derived from bone marrow and from skeletal muscle are capable of repairing damaged cardiac tissue after a heart attack.
  • Neural stem cells can form all neuron types, as they migrate throughout the brain to repair damage and to prevent the loss of neurons associated with Parkinson's disease.
  • Using the patient's own adult neural stem cells, a group at Los Angeles Cedars Sinai Medical Center reported a reversal of symptoms in the first Parkinson's patient who was treated by this method. (Reported at a meeting of the American Association of Neurological Surgeons, 4/8/02).
  • Certain types of cancer, such as lymphomas, multiple myeloma, leukemia, breast cancer, neuroblastoma, renal cell carcinoma, and ovarian cancer are treatable with adult stem cells.
  • Autoimmune diseases, such as multiple sclerosis, systemic lupus, rheumatoid arthritis, scleroderma, scleromyxedema, and Crohn's disease are treatable with adult stem cells.
  • Anemias (including sickle cell anemia) are treatable with adult stem cells.
  • Immunodeficiencies are treatable with adult stem cells.
  • Bone and cartilage deformities (such as childhood osteogenesis imperfecta) are treatable with adult stem cells.
  • Corneal scarring is treatable with adult stem cells (through the generation of new corneas to restore sight).
  • Neurological damage caused by stroke is treatable with adult stem cells.
  • Parkinson's disease is treatable using retinal stem cells or the patient's own neural stem cells.
  • Adult stem cells are able to induce the growth of new blood vessels (such as in the prevention of gangrene).
  • Adult stem cells are able to induce the growth of new gastrointestinal epithelia (and the regeneration of damaged ulcerous tissue).
  • Adult stem cells are able to induce the growth of new skin grafts (grown from hair follicle stem cells, after plucking a few hairs from the patient).

To recap, adult stem cells possess the following characteristics:

  • They are able to generate virtually all types of adult tissues.
  • They can multiply almost indefinitely, providing sufficient numbers for clinical treatments.
  • They have been repeatedly proven successful in laboratory cultures.
  • They have been repeatedly proven successful in animal models of disease..
  • They have been repeatedly proven successful in current clinical treatments.
  • They have the ability to "home in" on, and target, specific sites of tissue damage.
  • They avoid any problems with tumor formation.
  • They avoid any problems with transplant rejection.
  • They avoid any ethical quandaries.

Source: The Institute of Cellular Medicine